日本口腔診断学会雑誌
Online ISSN : 2188-2843
Print ISSN : 0914-9694
ISSN-L : 0914-9694
臨床報告
原発性副甲状腺機能亢進症患者に生じたMRONJ Stage Ⅲに対し外科療法が奏功した1例
木下 英荘小笠原 利行牧原 梨恵平井 里枝吉岡 愛西畑 貴喜
著者情報
ジャーナル フリー

2024 年 37 巻 1 号 p. 6-11

詳細
抄録
Primary hyperparathyroidism causes hypercalcemia due to continuous secretion of parathyroid hormone. Most cases are caused by benign adenoma, and excision of the adenoma is the first choice of treatment. However, in non-surgical cases, bisphosphonate is used to decrease serum calcium level and improve osteoporosis. A 59-year-old female patient complained of right submandibular pain accompanied by an external dental fistula in the right submandibular region and intraoral bone exposure in the right lower premolar region. CT images revealed the sequestrum in the right mandible. The patient had been taking an intravenous bisphosphonate for a relatively long period to improve hypercalcemia and osteoporosis. Therefore, we diagnosed medication-related osteonecrosis of the jaw (MRONJ) Stage Ⅲ, and conservative treatment was started. Since her condition did not improve, surgery was performed under general anesthesia to remove the sequestrum to the extent that fresh bone with bleeding could be confirmed. Postoperatively, the external dental fistula of the right submandibular region was closed, and the exposed bone in the oral cavity was covered with healthy oral mucosa. The patient’s progress is good.
著者関連情報
© 2024 日本口腔診断学会
前の記事 次の記事
feedback
Top